FISIOPATOLOGÍA Y FARMACOLOGÍA
Escuela de doctorado
Hospital Universitari de Tarragona Joan XXIII
Tarragona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Tarragona Joan XXIII (2)
2020
-
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes
Journal of Molecular Diagnostics, Vol. 22, Núm. 10, pp. 1217-1224
2018
-
Feasibility of treatment discontinuation in chronic myeloid leukemia in clinical practice: results from a nationwide series of 236 patients
Blood Cancer Journal, Vol. 8, Núm. 10